BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2783181)

  • 1. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
    Borella LE; DiJoseph JF; Mir GN
    Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiulcer activity and the mechanism of action of magaldrate in gastric ulceration models of rat.
    Patel AV; Santani DD; Goyal RK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):350-4. PubMed ID: 10941626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo.
    Schmidt C; Baumeister B; Kipnowski J; Miederer SE; Vetter H
    Hepatogastroenterology; 1998; 45(24):2443-6. PubMed ID: 9951941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
    Tariq M; Parmar NS; Ageel AM
    J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)].
    Dammann HG; Flashoff D; Müller P; Kather H; Simon B
    Dtsch Med Wochenschr; 1981 Oct; 106(44):1457-8. PubMed ID: 7297433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
    Borella LE; DiJoseph JF
    Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
    Baur C; Becker A; Linder R; Schwan T
    Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal protective activity of activated aluminum complex.
    DiJoseph JF; Borella LE; Wells CL; Mir GN
    Digestion; 1990; 45(1):19-25. PubMed ID: 2340961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric anti-ulcer and cytoprotective properties of 2-(3,4-dimethoxyphenyl)-5-methyl-thiazolidine-4-one in rat experimental ulcers.
    Matsuo Y; Kuwayama H; Itoh H; Seki A; Fukuda S; Kawasaki T; Hotta T; Ohsaka Y; Komatsu K
    Arzneimittelforschung; 1986 Aug; 36(8):1236-40. PubMed ID: 3778561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radicals and their interpretations.
    Jávor T; Past T; Nagy L; Mózsik G; Wittmann I
    Acta Physiol Hung; 1989; 73(2-3):323-30. PubMed ID: 2556889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiulcer activity of an anthocyanidin from Vaccinium myrtillus.
    Magistretti MJ; Conti M; Cristoni A
    Arzneimittelforschung; 1988 May; 38(5):686-90. PubMed ID: 3415709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE; Fábregas JL
    Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antisecretory, gastric anti-ulcer and cytoprotective properties of glycine.
    Tariq M; Al Moutaery AR
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):185-98. PubMed ID: 9344231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.